We strive to be totally transparent about our sources and uses of funds. We will give regular updates to provide donors, partner institutions, research teams, patients, and patient advocates with the relevant information about our needs and our spending.

Any money donated above and beyond our 2024 - 2025 goals will enable us to widen the scope of what we do: to support more projects, attract young researchers to the field, and contribute to the scientific infrastructure fundamental to all SMARCB1 cancer research.

All donations from the USA/Canada, Europe and the UK are tax-deductible.